Skip to main content


for people ages 18 years and up (full criteria)
healthy people welcome
at San Francisco, California
study started
estimated completion:



This study is a two-arm randomized controlled trial in which participants will receive either the Livongo Health system or iHealth glucose meter for measuring their blood glucose. The study hypothesizes the use of the Livongo Health system results in a greater improvement in A1c compared to standard blood glucose monitoring, as demonstrated by the iHealth Bluetooth-enabled glucose meter.

Official Title

Study of Unprecedented Glucose Analysis and Results: A Randomized Controlled Trial of the Effect of the Livongo Health Diabetes Management Program vs. Standard Care on Glycemic Control


Participants in this study will partake in study surveys, daily blood glucose monitor measurements, and blood sampling for the duration of their participation. The study intends to recruit and randomize 200 participants.


Diabetes Mellitus


You can join if…

Open to people ages 18 years and up

  • People with type 1 or 2 diabetes mellitus on any type of medication
  • Adults, age 18 years or older
  • Not using continuous glucose monitoring or an insulin pump
  • iOS Smartphone with access to data and/or Wi-Fi

You CAN'T join if...

  • Using continuous glucose monitoring during the study period
  • Using an insulin pump during the study period
  • Unable or unwilling to switch blood glucose meters to the study meter
  • Hospitalization for DKA or hypoglycemia in the past 1 month prior to enrollment
  • Pregnant patients, or intention to become pregnant during the study period


  • University of California, San Francisco not yet accepting patients
    San Francisco, California, 94158, United States


not yet accepting patients
Start Date
Completion Date
University of California, San Francisco
Phase 2
Lead Scientist
Jeffrey Olgin
Study Type
Last Updated
November 2016
I’m interested in this study!